Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

• Main Authors: Westerhout KY (Author), Bouwmeester W (Author), Duchesne I (Author), Pisini M (Author), Piena MA (Author), Damele F (Author), Gueron B (Author), Treur M (Author), Belsey J (Author)
• Format: Book
• Published: Dove Medical Press, 2017-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Kirsten Y Westerhout,1 Walter Bouwmeester,1 Inge Duchesne,2 Marta Pisini,2 Marjanne A Piena,1 Francesco Damele,3 Beatrice Gueron,2 Maarten Treur,1 Jonathan Belsey4 1Pharmerit BV, Marten Meesweg, Rotterdam, the Netherlands; 2Janssen EMEA, Turnhoutseweg, Beerse, Belgium; 3Janssen-Cilag SpA, Via Michel...